Dartmouth Named GammaTile Center of Excellence

Dartmouth Cancer Center, which is a center that practices the GammaTile innovation of brain tumor treatment, is acknowledged by GT Medical Technologies.

Dartmouth Cancer Center is the most recent employer of the GammaTile Center of Excellence Program of GT Medical Technologies, the industry leader in offering advanced treatment for brain tumors and clinical implementation of leading medical technology.

The label recognizes institutions and physicians that exhibit exceptional knowledge in the GammaTile procedure that satisfies high clinical standards, annual case volumes, and continuous training levels. A number of experts at Dartmouth were identified, such as neurosurgeons, radiation oncologists as well as neuro-oncologists who had much experience in complicated cases of brain tumors.

GammaTile is a type of technology that has significantly advanced medical treatment by providing targeted radiation during surgery to remove tumors. The treatment directly positions the radiation sources to the tumor site, allowing instantaneous treatment when the remaining cancer cells are in the most vulnerable location. By doing so, this method will eliminate the traditional waiting time between surgery and radiation, which is often required for the wound to heal.

Gap in treatment GammaTile will fill this treatment gap to enhance the local tumor containment and minimize the chance of recurrence. The method is designed to selectively provide radiation to patients, according to GT Medical Technologies, resulting in increased results.

The status of Dartmouth Cancer Center highlights the increased demand for medical technology that is revolutionizing neuro-oncology care. This is due to the fact that, as a growing number of individuals adopt it, GammaTile-based programs will increase in significance in helping better treat patients with brain tumors by making treatments more efficient, precise, and, overall, effective.